Engineering customized nanovaccines for enhanced cancer immunotherapy
Nanovaccines have gathered significant attention for their potential to elicit tumor-specific immunological responses. Despite notable progress in tumor immunotherapy, nanovaccines still encounter considerable challenges such as low delivery efficiency, limited targeting ability, and suboptimal effi...
Guardat en:
| Autors principals: | , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
KeAi Communications Co., Ltd.
2024-06-01
|
| Col·lecció: | Bioactive Materials |
| Matèries: | |
| Accés en línia: | http://www.sciencedirect.com/science/article/pii/S2452199X24000732 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|
